One paragraph (100 words): Therapeutic vaccines are biological drug designed to treat already diagnosed diseases or conditions by stimulating the body's immune system in order to fight pathogens or prevent further progression of disease. These vaccines play a major role in treatment of cancer, infectious diseases such as hepatitis B, HIV/AIDS, pneumonia etc. They can also help treat non-infectious chronic diseases such as cardiovascular disease, diabetes, neurological disorders.

The global therapeutic vaccines market is estimated to be valued at US$ 2.68 Bn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
Increasing incidence of chronic diseases is considered as one of the major drivers for growth of therapeutic vaccines market over the forecast period. According to World Health Organization (WHO), chronic diseases kill 41 million people each year, equivalent to 71% of all deaths globally. Cardiovascular diseases account for most chronic disease deaths, numbering 17.9 million people annually followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.6 million). Therapeutic vaccines help treat and control progression of these chronic diseases. Additionally growing focus on immunity enhancement for ageing population is also fueling the demand. Another key driver is technological advancements in vaccine development with increased focus on personalized medicine. Researchers are developing vaccines that target specific mutations in patient's tumor which is expected to improve efficacy of cancer treatment in future.

SWOT Analysis
Strength: Therapeutic vaccines are highly specific in their approach to treat diseases like cancer and infectious diseases and offer advantages over conventional therapies. They can be designed to target tumor-associated antigens or disease-causing pathogens. Administering therapeutic vaccines also poses fewer safety concerns than other treatments.
Weakness: Therapeutic vaccines often require multiple dosing over extended periods, which can reduce patient compliance. For some disease conditions with chronic or latent nature, their effectiveness is still limited. High development costs also make these vaccines expensive.
Opportunity: The rise in prevalence of chronic diseases worldwide, especially cancer, provides scope for increased adoption of novel therapeutic vaccines. Growing focus on personalized medicine also works in favor of developing targeted vaccines. Partnerships between drug makers and biotech firms can help address manufacturing challenges.
Threats: Stringent regulatory norms require extensive clinical testing, which increases uncertainty around therapeutic vaccine approvals. Development of resistant pathogen strains poses challenges to infectious disease vaccines. Alternate treatment options also threaten market uptake of new therapeutic vaccines.

Key Takeaways:
The Global Therapeutic Vaccines Market Demand is expected to witness high. The global therapeutic vaccines Market is estimated to be valued at US$ 2.68 Bn in 2024 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030.

The North America region currently dominates the global market for therapeutic vaccines due to high awareness levels and supportive regulatory guidelines. However, Asia Pacific is likely to emerge as the fastest growing regional market in coming years, driven by rising healthcare expenditure and increasing burden of chronic illnesses in developing nations.

Key players related content comprises Key players operating in the Therapeutic Vaccines market are AMR India Limited, Carmeu PBC, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., Inovio Pharmaceuticals, Merck & Co., Inc., Pfizer Inc., Sanofi, Valneva SE, and Immune Design Corp among others. Therapeutic vaccines developed by key players target various disease conditions including cancer, infectious diseases, autoimmune disorders, and neurological disorders. The market shows a growing interest in collaboration activities between firms to accelerate vaccine development.

Get more insights on this topic: https://www.newswirestats.com/therapeutic-vaccines-market-size-and-share-analysis-growth-trends-and-forecasts-2023-2030/

Explore more information on this topic, Please visit: https://filmik.in/cell-therapy-harmonizing-hope-through-the-therapeutic-rhythm-of-cellular-alchemy/